PLEASANTON, Calif., Oct. 16, 2012 (GLOBE NEWSWIRE) -- ZELTIQ Aesthetics, Inc. (Nasdaq:ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced that it has strengthened its management team with the addition of two aesthetic device industry veterans. Effective immediately, Len DeBenedictis has joined the Company as Chief Technology Officer and Keith J. Sullivan has joined as Senior Vice President of Worldwide Sales.
Mr. DeBenedictis, who has more than 35 years of experience as an inventor and executive in the medical device and technology industries, will lead the Company's R&D efforts as Chief Technology Officer, focusing on continued innovation and new product development. Mr. Sullivan, who has more than 30 years of experience in the medical device industry, will assume the role of SVP of Worldwide Sales, to better align and strengthen the Company's global sales efforts.
Mark Foley, President and Chief Executive Officer, said, "We are very excited to have Len and Keith join the organization based on their experience, credibility and success in the aesthetic space. Furthermore, we believe that their keen interest in joining ZELTIQ at this time reflects a shared view that the Company is uniquely positioned as the leader in non-invasive fat reduction. We are focused on building a world-class management team and feel that both Len and Keith underscore our commitment to this goal. In conjunction with adding Len and Keith to the team, we have realigned our R&D team as well as the Sales and Marketing organization. We believe that these changes will enhance our ability to accelerate new product innovation and to more successfully drive system sales and procedure revenue while ensuring a consistent global brand."Mr. DeBenedictis has 35 years of experience as a high technology pioneer, inventor and senior executive in the medical device and aesthetics industries. Most recently, Mr. DeBenedictis served as CTO of Cutera Inc, a leading provider of laser and other light-based aesthetic systems, where he led the R&D efforts. Previously, Mr. DeBenedictis served as CTO and Board Member of Solta Medical, a global provider of aesthetic treatments. Prior to Solta, Mr. DeBenedictis served as Co-Founder and Board Member of Reliant Technologies, where he conceived, developed and named the Fraxel Brand skin resurfacing products. Earlier in his career, Mr. DeBenedictis served in various executive and scientific roles at Coherent Medical Group, Spectra Physics Construction Systems, Atlantic Richfield, Xerox and Korad Lasers.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV